Neuro-Ophthalmology News

OCS-05 met safety and efficacy endpoints in the treatment of acute optic neuritis in a phase 2 trial, according to a press release from Oculis.

A deep learning system achieved an accuracy of more than 90% in distinguishing arteritic from nonarteritic anterior ischemic optic neuropathy using only color fundus images, according to a study published in JAMA Ophthalmology.

Among individuals who were prescribed approved biologics for neuromyelitis optica spectrum disorder, those on inebilizumab had significantly higher medication adherence, according to a study presented at ECTRIMS 2024.

The Bascom Palmer Eye Institute at University of Miami Miller School of Medicine has received $4.7 million from NIH to create imaging techniques that will detect changes in capillary function and help diagnose cerebral small vessel disease.

The first 100 patients have been enrolled in a clinical trial investigating a novel light therapy device intended to treat individuals with Parkinson’s disease, according to the manufacturer.

Neurotechnology company Synchron announced the first use of Apple Vision Pro with a patient implanted with its brain-computer interface, which allows users to make commands without using their hands or voice.

PHILADELPHIA — In this video, Michael Fisher, MD, discusses the results of a natural history study he presented at the International Symposium on Pediatric Neuro-Oncology.

SAN DIEGO – Spontaneous intracranial hypotension led to significant physical, mental and quality of life impact for a cohort of those with the condition, according to a speaker at the American Headache Society Annual Scientific Meeting.

Patients with idiopathic infantile nystagmus syndrome had better best-corrected visual acuity but scored lower on quality-of-life assessments compared with those whose condition was associated with ocular disease, according to research.